Active, Not Recruiting
Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)
NCT02726997
- Conditions
- Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +24 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States